Inside the study for a remedy to fight Congo's deadliest Ebola outbreak
More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
How blood vessels distinguish between growth and inflammation
United Kingdom
-
New technology advances understanding of eye pressure and glaucoma
United Kingdom
-
Rare 1-in-100M ‘Ghost Lobster’ Goes to School to Help Scientists Crack Genetic Mystery–in Time for Halloween
United Kingdom
-
Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
United Kingdom
-
Polyubiquitin may stabilize tau filament structures in neurodegenerative diesases
United Kingdom
Original: Polyubiquitin may stabilize tau filament structures in neurodegenerative diseases
-
G7 countries reluctantly agree to tap their fuel reserves to help the U.S.
United States
-
Irrelevant visual details interfere with decisions under uncertainty, brain research shows
United Kingdom
-
Your gut bacteria may reveal how fast your brain is aging
United States